https://www.selleckchem.com/pr....oducts/bay-2666605.h
tasets prior to any clinical adoption. We have developed new lesion-level response and progression models using textural radiomics features, derived from 90Y PET combined with mean absorbed dose for predicting outcome in radioembolization. These encouraging, but limited results, will need further validation in independent and larger datasets prior to any clinical adoption.Although intestinal microbiome have been established as an important biomarker and regulator of cancer development and therapeutic response, less is known about th
Like
Comment
Share
